Pureskin Liquid Wart Corn Removal Mask

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the available information.

Uses and Indications

This drug is indicated for the treatment of corns, calluses, flat warts, plantar warts, and common warts measuring less than 5 mm in diameter.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area, such as corns or warts, should be soaked in warm water for 5 minutes to soften the skin. Following this, the brush must be installed into the bottle cap by pressing tightly and ensuring the cap is securely tightened. After drying the skin, the lid should be opened, and the brush dipped into the liquid. The liquid is then to be applied directly onto the wart or corn using the brush.

Once the initial application is made, it is important to wait for a mask to form before applying the liquid again. The recommended frequency of application is twice during the day and twice at night. Treatment should continue for a duration of 2 weeks, or until the skin has recovered its health. In cases where the corns or warts are particularly large, a longer treatment period may be necessary.

Contraindications

Use of this product is contraindicated in the following situations:

Application on broken skin or the eye area is prohibited due to the potential for irritation and adverse effects. Additionally, individuals with a known allergy to this product should refrain from use to avoid allergic reactions.

Warnings and Precautions

For external use only, this product should not be applied to the face or any healthy skin. In the event of contact with the eyes, it is imperative to flush the area with water immediately to mitigate potential irritation.

It is crucial to avoid using this product on broken skin or in the eye area, as this may lead to adverse effects. Healthcare professionals should advise patients to discontinue use and consult a physician if they experience any allergic reactions to the product. Additionally, if symptoms persist for more than 7 days or worsen, patients should seek medical advice promptly.

While no specific emergency medical instructions are provided, it is always advisable for patients to seek immediate medical assistance if they experience severe reactions or complications.

Currently, there are no recommended laboratory tests associated with the safe use of this product.

Side Effects

Patients using this product should be aware that it is for external use only and must avoid contact with the face or healthy skin. In the event of contact with the eyes, it is imperative to flush with water immediately.

Serious adverse reactions may occur in patients who are allergic to this product. Symptoms of an allergic reaction may necessitate discontinuation of use. Patients are advised to stop using the product if symptoms persist for more than 7 days or worsen.

Additionally, patients should consult their physician if they are pregnant, breastfeeding, or planning to become pregnant while using this product. It is crucial for patients to seek medical advice if they experience any adverse reactions or if their symptoms do not improve within the specified timeframe.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Pureskin Liquid Wart Corn Removal Mask (liquid wart corn removal mask). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and caution is advised when administering this medication to younger individuals.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those planning to become pregnant should consult their healthcare provider before using this product. It is important for women of childbearing potential to discuss their pregnancy status with their doctor, especially if they become pregnant or are planning to become pregnant while using this medication. The potential risks and benefits should be carefully evaluated in these situations to ensure the safety of both the patient and the fetus.

Lactation

Lactating mothers are advised to consult their physician if they are pregnant or breastfeeding. There is no specific data provided regarding the excretion of the drug in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Healthcare professionals should be prepared to provide comprehensive information regarding the substance involved and the circumstances of the overdose to facilitate appropriate management and treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. Patients should be instructed not to use the product on broken skin or in the eye area, as this may lead to adverse effects.

It is important for healthcare providers to inquire about any known allergies to the product before recommending its use. Patients should be informed to discontinue use and consult their physician if symptoms persist for more than 7 days or worsen. Additionally, patients should be cautioned to avoid contact with the face or healthy skin, and to flush with water immediately if the product comes into contact with their eyes.

Healthcare providers should also discuss the implications of using the product during pregnancy or while breastfeeding. Patients should be advised to inform their healthcare provider if they become pregnant or are planning to become pregnant while using this product.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to protect its efficacy. Additionally, it is essential to keep the product out of reach of children to ensure safety.

Additional Clinical Information

The medication is administered topically, with a recommended frequency of twice during the day and twice at night. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Pureskin Liquid Wart Corn Removal Mask, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)